Laboratory of Clinical Studies, NIAAA, DICBR, Bethesda MD 20892, USA.
J Psychopharmacol. 1993 Jan;7(4):305-15. doi: 10.1177/026988119300700401.
Fifteen normal volunteers were administered placebo, 0.250, 0.375 and 0.500 mg of triazolam in a double- blind cross-over design. Triazolam induced robust dose-dependent impairments in explicit memory of information presented after drug administration. Subjects were unaware of their memory deficit (an impairment in meta-cognition). In contrast, memory for information presented prior to the administration of triazolam was facilitated following the administration of low doses of triazolam. Implicit memory and access to knowledge memory was unaltered by this benzodiazepine. An analysis of these results controlling for concurrent sedation as measured subjectively, through the use of self rating scales and objectively, based upon psychomotor performance, demonstrated that the amnestic effects of triazolam are largely independent of sedative effects. The pattern of memory changes induced by benzodiazepines, such as triazolam, is similar to the memory inpairment expressed in amnestic patients but unlike the pattern of impaired memory evident in dementia such as Alzheimer's disease.
15 名正常志愿者接受了安慰剂、0.250、0.375 和 0.500mg 的三唑仑,采用双盲交叉设计。三唑仑导致明显的、剂量依赖性的、药物给药后呈现的信息的外显记忆损伤。受测者没有意识到自己的记忆缺陷(元认知损伤)。相比之下,在低剂量三唑仑给药后,记忆呈现之前的信息得到了促进。这种苯二氮䓬类药物对内隐记忆和知识记忆的获取没有影响。通过使用自我评估量表和基于精神运动表现的客观评估,对这些结果进行了分析,以控制同时发生的镇静作用,结果表明,三唑仑的遗忘效应在很大程度上独立于镇静作用。苯二氮䓬类药物(如三唑仑)引起的记忆变化模式与遗忘症患者的记忆损伤相似,但与阿尔茨海默病等痴呆症中明显的记忆损伤模式不同。